ALNY · Alnylam Pharmaceuticals, Inc. · Debt
$246.74
-7.33 (-2.89%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$34.17B
Shares
133.81M
Volume · Sep 30
1.04M
Avg daily vol (3M)
1.8M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
20 filings
16 filers
Visit website
Investor relations